Skip to main content
Proceedings of the Royal Society B: Biological Sciences logoLink to Proceedings of the Royal Society B: Biological Sciences
. 2021 Nov 17;288(1963):20211651. doi: 10.1098/rspb.2021.1651

Predicting the zoonotic capacity of mammals to transmit SARS-CoV-2

Ilya R Fischhoff 1,, Adrian A Castellanos 1,, João P G L M Rodrigues 2, Arvind Varsani 3,4, Barbara A Han 1,
PMCID: PMC8596006  PMID: 34784766

Abstract

Back and forth transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) between humans and animals will establish wild reservoirs of virus that endanger long-term efforts to control COVID-19 in people and to protect vulnerable animal populations. Better targeting surveillance and laboratory experiments to validate zoonotic potential requires predicting high-risk host species. A major bottleneck to this effort is the few species with available sequences for angiotensin-converting enzyme 2 receptor, a key receptor required for viral cell entry. We overcome this bottleneck by combining species' ecological and biological traits with three-dimensional modelling of host-virus protein–protein interactions using machine learning. This approach enables predictions about the zoonotic capacity of SARS-CoV-2 for greater than 5000 mammals—an order of magnitude more species than previously possible. Our predictions are strongly corroborated by in vivo studies. The predicted zoonotic capacity and proximity to humans suggest enhanced transmission risk from several common mammals, and priority areas of geographic overlap between these species and global COVID-19 hotspots. With molecular data available for only a small fraction of potential animal hosts, linking data across biological scales offers a conceptual advance that may expand our predictive modelling capacity for zoonotic viruses with similarly unknown host ranges.

Keywords: COVID-19, ecological traits, zoonotic, spillback, machine learning, structural modelling

1. Introduction

The ongoing COVID-19 pandemic has surpassed 4.8 million deaths globally as of 1 October 2021 [1,2]. Like previous pandemics in recorded history, COVID-19 originated from the spillover of a zoonotic pathogen, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a betacoronavirus originating from an unknown animal host [36]. The broad host range of SARS-CoV-2 is due in part to its use of a highly conserved cell surface receptor to enter host cells, the angiotensin-converting enzyme 2 receptor (ACE2) [7] found in all major vertebrate groups [8].

The ubiquity of ACE2 coupled with the high prevalence of SARS-CoV-2 in the global human population explains multiple observed spillback infections since the emergence of SARS-CoV-2 in 2019 (see natural infections listed in electronic supplementary material, table S1). In spillback infection, human hosts transmit SARS-CoV-2 virus to cause infection in non-human animals. In addition to threatening wildlife and domestic animals, repeated spillback infections may lead to the establishment of new animal hosts from which SARS-CoV-2 can then pose a risk of secondary spillover infection to humans through bridge hosts (e.g. [9]) or newly established enzootic reservoirs. Indeed, this risk has been realized in Denmark [10] and The Netherlands, where SARS-CoV-2 spilled back from humans to farmed mink (Neovison vison) with the secondary spillover of a SARS-CoV-2 variant from mink back to humans [11]. A major concern in such secondary spillover events is the appearance of a mutant strain affecting host range [12] or leading to increased transmissibility in humans [13,14] (but see [15,16]), reduced sensitivity to neutralizing antibodies [10] and reduced vaccine efficacy [17]. Conversely, human-derived variants pose spillback risks to animals. For example, in contrast with previous infection trials [18], two new human variants have overcome the species barrier to infect laboratory mice (Mus musculus) [19].

Spillback infections from humans to animals are already occurring worldwide with pets, domesticated animals, zoo animals and wildlife now documented as new hosts of SARS-CoV-2 (figure 1; electronic supplementary material, table S1). SARS-CoV-2 has been found for the first time in wild and escaped mink in multiple states in the United States, with viral sequences identical to SARS-CoV-2 in nearby farmed mink [3335]. The global scale of human infections and the increasing range of known animal hosts demonstrate that SARS-CoV-2 has the capacity to establish novel infection cycles in animals. In response, recent computational studies predict the susceptibility of particular animal species to SARS-CoV-2 [12,2128,36] by comparing known sequences of ACE2 orthologues across species (sequence-based studies), or by modelling the structure of the viral spike protein bound to ACE2 orthologues (structure-based studies) to yield a wide range of predictions with varying degrees of agreement with laboratory animal experiments (figure 1).

Figure 1.

Figure 1.

A heatmap summarizing predicted susceptibility to SARS-CoV-2 for species with confirmed infection from in vivo experimental studies or from documented natural infections. Studies that make predictions about species susceptibility are shown on the x-axis, organized by the method of prediction (those relying on ACE2 sequences, estimating binding strength using three-dimensional structures, or laboratory experiments). Predictions about zoonotic capacity from this study are listed in the second to last column, with high and low categories determined by zoonotic capacity observed in Felis catus. Confirmed infections for species along with the y-axis are depicted as a series of filled or unfilled circles. Bolded species have been experimentally confirmed to transmit SARS-CoV-2 to naive conspecifics. Species predictions range from warmer colours (yellow: low susceptibility or zoonotic capacity for SARS-CoV-2) to cooler colours (purple: high susceptibility or zoonotic capacity). See electronic supplementary material, Methods [20] for detailed methods about how predictions from past studies were categorized as low, medium or high. For a comparison of predictions of species susceptibility from multiple methods, including our study, see electronic supplementary material, figure S1. (Online version in colour.)

Sequence-based studies predict host susceptibility based on amino acid sequence similarity between human (hACE2) and non-human ACE2, and assume that a high degree of similarity correlates with stronger viral binding, especially at amino acid residues where hACE2 interacts with the SARS-CoV-2 spike glycoprotein. For some species, such as rhesus macaques [37], these qualitative predictions are borne out by in vivo studies (figure 1), but predictions from these methods do not consistently match real-world outcomes. For example, sequence similarity predicted weak viral binding for minks and ferrets, which have both been confirmed as highly susceptible [11,22,38] (figure 1). Mismatches to in vivo outcomes may arise in part because protein three-dimensional structure, the main determinant of the interaction between host ACE2 and the viral spike protein, is incompletely represented by one-dimensional amino acid sequences [39,40].

Structure-based studies model the three-dimensional structure of protein-protein complexes to address some of the limitations of sequence-based approaches. Structural models have proven useful for predicting how different ACE2 orthologues bind to the SARS-CoV-2 viral spike protein receptor-binding domain (RBD) [12,28]. These studies leverage known structures of the hACE2 receptor bound to the SARS-CoV-2 RBD and use powerful simulations to predict how variation across different ACE2 orthologues affects binding with the viral RBD. While these approaches successfully predicted strong binding for species that have been infected (e.g. domestic cat, tiger, dog and ferret) and weak binding for species in which experimental infections have failed (e.g. chicken, duck [38], mouse [18]), the results are also not consistently supported by experiments. For instance, while guinea pig ACE2 scored favourably in one structure-based study [12], this orthologue was shown experimentally not to bind to the SARS-CoV-2 RBD [29].

Although structural modelling has produced the most accurate results to date, all currently available approaches for predicting the host range of SARS-CoV-2 are fundamentally constrained by the availability of ACE2 sequences across species. ACE2 is ubiquitous across chordates, probably because of its role in highly conserved physiological pathways, for example in regulating blood pressure, salt and water [41]. The vast majority of mammal species (greater than 6000 species) are likely to have ACE2, but sequences are available for only around 300 species. The functional importance of the ACE2 receptor suggests that it has evolved in association with other intrinsic organismal traits for which data are available for many more species. These suites of correlated organismal traits may provide a robust statistical proxy that can be leveraged to predict biologically permissive hosts for SARS-CoV-2. Previous trait-based analyses applied machine learning techniques to accurately distinguish the zoonotic capacity of various organisms [4244] and predict likely hosts for particular groups of related viruses [45,46], predictions which have subsequently been validated through independent laboratory and field investigations (e.g. [47,48]).

Here, we combine structural modelling of viral binding with machine learning of species ecological and biological traits to predict zoonotic capacity for SARS-CoV-2 across 5400 mammal species, expanding our predictive capacity by an order of magnitude (figure 2). Crucially, this integrated approach enables predictions for the vast majority of species whose ACE2 sequences are currently unavailable by leveraging information from viral binding dynamics and biological traits. In our workflow (figure 2), we first carry out structural modelling to quantify the binding strength of SARS-CoV-2 RBD for vertebrate species using published ACE2 amino acid sequences [49]. We then collate species traits and train a machine learning model to predict the zoonotic capacity for 5400 mammals.

Figure 2.

Figure 2.

A flowchart showing the progression of our workflow combining evidence from limited laboratory and field studies with additional data types to predict zoonotic capacity across mammals through multi-scale statistical modelling (grey boxes, steps 1–5). For all vertebrates with published ACE2 sequences, we modelled the interface of species' ACE2 bound to the viral RBD using HADDOCK. We then combined the HADDOCK scores, which approximate binding strength, with species' trait data and trained machine learning models (generalized boosted regression) for both mammals and vertebrates. Predictive modelling of host zoonotic capacity focused on mammals only because there are currently no non-mammalian hosts for SARS-CoV-2 and imbalanced ACE2 sequences among non-mammals. Mammal species predicted to have high zoonotic capacity were then compared to results of in vivo experiments and in silico studies that applied various computational approaches. Based on predictions from our model, we identified a subset of species with particularly high risk of spillback and secondary spillover potential to prioritize additional laboratory validation and field surveillance (dashed line). (Online version in colour.)

As COVID-19 is primarily a disease affecting humans, spillback infection of SARS-CoV-2 from humans to animals is the most likely mode by which new animal hosts will become established. We therefore identify a subset of species for which the threat of spillback infection appears greatest due to geographic overlaps and opportunities for contact with humans in areas of high SARS-CoV-2 prevalence globally. These approaches underscore the utility of establishing interdisciplinary and iterative processes that join computational modelling, field surveillance and laboratory experiments to more efficiently quantify zoonotic risk [50], and better inform next steps to prevent enzootic SARS-CoV-2 transmission and spread. Our analyses are based on the initial dominant SARS-CoV-2 variant in humans, but these methods can be readily adjusted to enable host range predictions for new variants as their hACE2-RBD crystal structures become available.

2. Methods

(a) . Structural modelling of ACE2 orthologues bound to SARS-CoV-2 spike

We assembled ACE2 sequences from the NCBI GenBank and MEROPS databases. The modelling of 326 ACE2 orthologues bound to SARS-CoV-2 spike RBD was carried out using the HADDOCK software as described previously [13], with a few differences. For details on how we processed sequences, and on our structural modelling of ACE2 orthologues bound to SARS-CoV-2 spike (PDB ID: 6m0j [51]; see electronic supplementary material, Methods [20]). For each species, we estimated binding strength based on HADDOCK score—a combination of van der Waals, electrostatics and desolvation energies. A lower (more negative) HADDOCK score predicts stronger binding between the two proteins. We hereafter refer to predicted binding strength, or simply binding strength, to indicate HADDOCK score. The HADDOCK server is freely available, and we provide code to reproduce analyses or to aid in the application of this modelling approach to similar problems [52]. Though the effects of multiple simultaneous mutations on binding affinity remain difficult to predict, HADDOCK has been used to explore how minor changes to the structure of the RBD (e.g. from point mutations or deletions in SARS-CoV-2 variants) affect viral binding [12]. These variations are accounted for by the HADDOCK software by estimating and considering their effects on both strong and weak forces that together determine both local and interfacial molecular contacts [53]. As crystal structures of novel variants become available, the modelling pipeline we present here can be applied to predict how differences in binding strengths to ACE2 orthologues affect host range and the risk of spillover transmission across species.

(b) . Trait data collection and cleaning

We gathered ecological, life history, phylogenetic and biological trait data from AnAge [54], Amniote Life History Database [55], EltonTraits [56], PanTHERIA [57] and taxonomic databases [58], among other databases. Non-mammal hosts have yet to be confirmed as both susceptible and capable of onward transmission of SARS-CoV-2. Therefore, while we gathered data on certain traits across all vertebrates, we gathered data on additional traits for mammals. For mammal species, we applied boosted regression (BRT) using the gbm package [59] in R v. 4.0.0 [60] to impute missing trait data (e.g. [44]; see electronic supplementary material, Methods for imputation methods and results). Data and descriptions of each variable can be found in the electronic supplementary material, table S2. For details on data processing, see electronic supplementary material, Methods [20].

(c) . Modelling

(i) . Quantifying a threshold for zoonotic capacity using HADDOCK

ACE2 binding is necessary for viral entry into host cells, but it is not sufficient for SARS-CoV-2 transmission. Multiple in vivo experiments suggest that some species are capable of binding SARS-CoV-2 but not capable of transmitting active infection to other individuals (e.g. cattle, Bos taurus [61]; bank voles, Myodes glareolus [62]). Viral replication and viral shedding that enables onward transmission are both required to become a suitable bridge or reservoir host for SARS-CoV-2. We constrained our predictions to species with the greatest potential for onward transmission by training our models on a binary label created using a conservative threshold of binding strength (HADDOCK score = −129). This value falls between the scores for two species: the domestic cat (Felis catus), currently the species with weakest predicted binding but confirmed conspecific transmission [63], and the pig (Sus scrofa), which shows the strongest estimated binding for which experimental inoculation failed to cause detectable infection [38]. Binding strength was binarized according to this threshold, above which it is more likely that both infection and onward transmission will occur following the results of multiple empirical studies (figure 1; electronic supplementary material, table S1). There are susceptible species whose predicted binding strength is weaker than cats, but conspecific transmission has not been confirmed in these species. For additional modelling details, see electronic supplementary material, Methods.

(d) . Trait-based modelling to predict zoonotic capacity

We applied generalized BRT [64] to host trait data to predict mammal species’ zoonotic capacity (for descriptions and results from additional uninformative models, including models using a vertebrate dataset, see electronic supplementary material, Methods and electronic supplementary material table S3). Code for BRT modelling, along with data for training models and making predictions, can be found at https://github.com/HanLabDiseaseEcology/zoonotic_capacity.

3. Results

Currently available ACE2 protein sequences came from 326 species spanning eight classes and 87 orders [52]. The majority of sequences belonged to the classes Actinopterygii (22.1%), Aves (23.3%) and Mammalia (46.6%). We predicted binding strength for 299 vertebrates, including 142 mammals (electronic supplementary material, figures S2–S6). Among well-represented mammalian orders (those containing at least 10 species with binding strength predictions), Primates and Carnivora showed predicted mean binding strengths that were stronger than domestic cats (electronic supplementary material, figure S2).

We next constructed a trait-based machine learning model to predict zoonotic capacity (a binarized binding threshold) in mammals. We used the best-performing model to generate predictions of zoonotic capacity among mammal species (corrected test AUC of 0.72; for results of all other model variations see electronic supplementary material, table S3). Citation count in Web of Science, used as a proxy for study effort, had approximately 1% relative importance (electronic supplementary material, figure S7), suggesting that sampling bias across species had little influence on the model.

This model predicted 540 species spanning 13 orders to have zoonotic capacity within the 90th percentile (0.826 or higher, with a total of 2401 mammal species with prediction scores above 0.5; see electronic supplementary material, file S1 for predictions on all 5400 species [20]). Most primates were predicted to have high zoonotic capacity and collectively showed stronger viral binding compared to other mammal groups (figure 3). Additional orders predicted to have high zoonotic capacity (at least 75% of species above 0.5) include Hyracoidea (hyraxes), Perissodactyla (odd-toed ungulates), Scandentia (treeshrews), Pilosa (sloths and anteaters), Pholidota (pangolins) and non-cetacean Artiodactyla (even-toed ungulates) (figure 3). Results of model bootstrap iteration predictions can be found in the electronic supplementary material, file S1 and electronic supplementary material figure S10.

Figure 3.

Figure 3.

Ridgeline plots showing the distribution of predicted zoonotic capacity across mammals. Predicted probabilities for zoonotic capacity across the x-axis range from 0 (likely not susceptible) to 1 (zoonotic capacity predicted to be the same or greater than Felis catus), with the vertical line representing 0.5. The y-axis depicts all mammalian orders represented by our predictions. Density curves represent the distribution of the predictions, with those parts of the curve over 0.5 coloured pink and lines representing distribution quartiles. The predicted values for each order are shown as points below the density curves. Points that were used to train the model are coloured: orange represents species with weaker predicted binding, blue represents species with stronger predicted binding. Selected family-level distributions are shown in the electronic supplementary material, figures S8 and S9 [20]. (Online version in colour.)

(a) . Comparing model predictions to in vivo outcomes

These model predictions matched the experimental infection outcomes of several in vivo studies (figure 1). For instance, experiments on deer mice (Peromyscus maniculatus [65,66]) and raccoon dogs (Nyctereutes procyonoides [67]) confirmed SARS-CoV-2 infection and transmission to naive conspecifics. Our model also estimated a high probability of zoonotic capacity of American mink for SARS-CoV-2 (Neovison vison, probability = 0.83, 90th percentile), in which farmed individuals present severe infection and demonstrate the capacity to transmit to conspecifics as well as to humans [11]. Our model also correctly predicted relatively low zoonotic capacity for big brown bats (Eptesicus fuscus [68]).

There were notable differences between our model results and currently available experimental studies. Our model estimated high zoonotic capacity for pigs (Sus scrofa, probability = 0.72, approximately 80th percentile), but in vivo studies report no detectable infection or onward transmission [38,69]. Similarly for cattle (Bos taurus), our model estimated a moderately high probability for zoonotic capacity (0.72, approximately 80th percentile), whereas in a live animal experiment, cattle were susceptible but with no onward transmission to conspecifics [61].

4. Discussion

We combined structure-based models of viral binding with species-level data on biological and ecological traits to predict the capacity of mammal species to become zoonotic hosts of SARS-CoV-2 (zoonotic capacity). Importantly, this approach extends our predictive capacity beyond the limited number of species for which ACE2 sequences are currently available. Numerous mammal species were predicted to have zoonotic capacity that meets or exceeds the viral susceptibility and transmissibility observed in experimental infections with SARS-CoV-2 (figure 1; electronic supplementary material, table S1). Many species with high model-predicted zoonotic capacity also live in human-associated habitats and overlap geographically with global COVID-19 hotspots (figure 4). Below we discuss predictions of zoonotic capacity for a number of ecologically and epidemiologically relevant categories of mammalian hosts.

Figure 4.

Figure 4.

Maps showing the global distribution of species with the predicted capacity to transmit SARS-CoV-2; (a) depicts global species richness of the top 10 per cent of model-predicted zoonotic capacity. Geographic ranges of this subset of species were filtered to those associated with human-dominated or human-altered habitats (b), and further filtered to show the subset of species that overlaps with areas of high human SARS-CoV-2 positive case counts (over 100 000 cumulative cases as of 17 May 2021) (c). For a full list of model-predicted zoonotic capacity of species by country, see electronic supplementary material, file S2 [20]. (Online version in colour.)

(a) . Captive, farmed or domesticated species

Given that contact with humans fundamentally underlies transmission risk, it is notable that our model predicted high zoonotic capacity for multiple captive species that have also been confirmed as susceptible to SARS-CoV-2. These include numerous carnivores, such as large cats from multiple zoos and pet dogs and cats. Our model also predicted high SARS-CoV-2 zoonotic capacity for many farmed and domesticated species. The water buffalo (Bubalus bubalis), widely kept for dairy and plowing, had the highest probability of zoonotic capacity among livestock (0.91). Model predictions in the 90th percentile also included American mink (Neovison vison), red fox (Vulpes vulpes), sika deer (Cervus nippon), white-lipped peccary (Tayassu pecari), nilgai (Boselaphus tragocamelus) and raccoon dogs (Nyctereutes procyonoides), all of which are farmed. The escape of farmed individuals into wild populations has implications for the enzootic establishment of SARS-CoV-2 [33]. These findings also have implications for vaccination strategies, for instance, prioritizing people in contact with potential bridge species (e.g. slaughterhouse workers, farmers, veterinarians).

(b) . Live traded or hunted wildlife species

The Macaca genus comprised the majority of live-traded primates. Our model predicted high zoonotic capacity for all Macaca species (20/21 species, with all species within the top 10% of predictions except M. assamensis). Several live-traded carnivores and pangolins were also assigned high zoonotic capacity, including the Asiatic black bear (Ursus thibetanus), grey wolf (Canis lupus) and jaguar (Panthera onca), and the Philippine pangolin (Manis culionensis) and Sunda pangolin (M. javanica). One of the betacoronaviruses with the highest sequence similarity to SARS-CoV-2 was isolated from Sunda pangolins [70]. Interestingly, pangolin burrows are known to be occupied by other animal species, including numerous bats [71].

Commonly hunted species in the top 10% of predictions include duiker (Cephalophus zebra, West Africa), warty pig (Sus celebes, Southeast Asia) and two deer (Odocoileus hemionus and O. virginianus, Americas). The white-tailed deer (O. virginianus) was recently confirmed to transmit SARS-CoV-2 to conspecifics via aerosolized virus particles [72].

(c) . Bats

Our model identified 35 bat species within the 90th percentile of zoonotic capacity. Within the genus Rhinolophus, our model identified the large rufous horseshoe bat (Rhinolophus rufus) as having the highest probability of zoonotic capacity (0.89). Rhinolophus rufus is a known natural host for bat betacoronaviruses [73] and a congener to three other horseshoe bats harbouring betacoronaviruses with high nucleotide sequence similarity to SARS-CoV-2 (approx. 92–96%) [6,74,75]. For these other three species, our model assigned a range of probabilities for SARS-CoV-2 zoonotic capacity (Rhinolophus affinis (0.58), R. malayanus (0.70) and R. shameli (0.71)) and also predicted relatively high probabilities for two congeners, Rhinolophus acuminatus (0.84) and R. macrotis (0.70). These predictions agree with recent experiments demonstrating efficient viral binding of SARS-CoV-2 RBD for R. macrotis [76] and confirmation of SARS-CoV-2-neutralizing antibodies in field-caught R. acuminatus harbouring a closely related betacoronavirus [77].

Our model also identified 17 species in the genus Pteropus (flying foxes) with high probabilities of zoonotic capacity for SARS-CoV-2. Some of these species are confirmed reservoirs of other zoonotic viruses (e.g. henipaviruses in P. lylei, P. vampyrus, P. conspicillatus and P. alecto), with Southeast Asia also having the most mammal species with a high predicted zoonotic capacity (figure 4). Annual outbreaks attributed to spillover transmission from bats illustrate a persistent epizootic risk to humans [7880] and confirm that gaps in systematic surveillance of zoonotic viruses, including betacoronaviruses, remain an urgent priority (e.g. [81]).

(d) . Rodents

Our model identified 76 rodent species with high zoonotic capacity. Among these are the deer mouse (Peromyscus maniculatus) and white-footed mouse (P. leucopus), which are reservoirs for multiple zoonotic pathogens and parasites in North America [8284]. Experimental infection, viral shedding and sustained intraspecific transmission of SARS-CoV-2 were recently confirmed for P. maniculatus [65,66]. Also in the top 10% were two rodents considered to be human commensals whose geographic ranges are expanding due to human activities: Rattus argentiventer (0.84) and R. tiomanicus (0.79) (electronic supplementary material, file S1) [8587]. It is notable that many of these rodent species are preyed upon by carnivores, such as the red fox (Vulpes vulpes) or domestic cats (Felis catus) who themselves were predicted to have high zoonotic capacity by our model.

(e) . Strengthening predictive capacity for zoonoses

While there was a wide agreement between our model predictions and empirical studies, examining mismatches between experimental results and model-generated predictions focuses attention on characterizing what factors underlie these disconnects. For instance, this study and others predicted that pigs (Sus scrofa) would be susceptible to SARS-CoV-2 (figure 1), but these predictions have not been supported by whole-animal inoculations [38,69]. Similarly, SARS-CoV-2 replicated in adult cattle but onward transmission has not been observed in vivo [61].

Disconnects between real-world observations, in vivo experimental results, and in silico predictions of zoonotic capacity offer insight upon which to iterate further study. For instance, mismatches may arise because host susceptibility and transmission capacity are necessary but not sufficient for zoonotic risk to be realized in natural settings. These processes are embedded in a broader ecological context that impacts host susceptibility, intra-host infection dynamics (latency, recrudescence, tolerance) and viral persistence that collectively determine where and when viral shedding and spillover will occur [8891]. Infection processes also depend strongly on the cellular environments in which cell entry and viral replication take place (e.g. the presence of key proteases [7]), and on host immunogenicity [91], factors which are themselves influenced by the environment [92]. Insofar as data limitations preclude perfect computational predictions of zoonotic capacity (e.g. limited ACE2 sequences, crystal structures or trait data), laboratory experiments are also limited. For SARS-CoV-2 and other host–pathogen systems, animals that are readily infected in the laboratory may be less susceptible elsewhere (ferrets in the laboratory versus mixed results in ferrets as pets [69,93,94]; rabbits in the laboratory versus rabbits as pets [95,96]). Moreover, wildlife hosts confirmed to shed multiple zoonotic viruses in nature (e.g. bats [97]) can be much less tractable for whole-animal laboratory investigations (for instance, requiring high biosecurity containment and very limited sample sizes). While laboratory experiments are critical for understanding mechanisms of pathogenesis and disease, without field surveillance they offer imperfect reflections of zoonotic capacity realized in natural settings.

These examples illustrate that there is no single methodology sufficient to understand and predict zoonotic transmission, for SARS-CoV-2 or any zoonotic pathogen. They also demonstrate the need to capitalize on underused or disconnected data sources, such as natural history collections, which are well-positioned to fill knowledge gaps about the spatial and temporal extents of animal hosts and their pathogens [98,99]. Integration of methods and data across biological scales creates avenues to more efficient iteration between computational predictions, laboratory experiments and targeted animal surveillance necessary to connect transmission mechanisms to the broader conditions underpinning zoonotic disease emergence in nature.

Supplementary Material

Acknowledgements

We are grateful for discussions with Drs. Alexandre Bonvin, Dennis Bente, Susan Hafenstein, Kathryn Hanley, Hyunwook Lee, Colin Parrish and John Paul Schmidt about various components of this project.

Data accessibility

All data, code and models required for recreating our structural modelling analysis with HADDOCK are available from Zenodo: https://doi.org/10.5281/zenodo.4517509) [52]. All data and code required for BRT modelling using species trait data are available from GitHub: https://github.com/HanLabDiseaseEcology/zoonotic_capacity. Additional methods, tables, figures and files of our model predictions can be found in the supplemental material of this article and on Figshare: https://doi.org/10.25390/caryinstitute.c.5293339.v5 [20].

Authors' contributions

I.R.F., A.A.C. and B.A.H. were responsible for conceptualization, data curation, formal analysis, investigation, methodology, project administration, software, and writing, reviewing and editing the manuscript. J.P.G.L.M.R. contributed additional analysis. J.P.G.L.M.R., A.V. and B.A.H. contributed funding. A.V. and A.A.C. created all figures. All authors gave final approval for publication and agreed to be held accountable for the work performed therein.

Competing interests

We declare we have no competing interests.

Funding

This work was supported by the NSF EEID program (grant no. DEB 1717282), DARPA PREEMPT program (grant no. D18AC00031), CREATE-NEO, a member of the NIH NIAID CREID program (grant no. 1U01 AI151807-01) and the NVIDIA Corporation GPU grant program (B.A.H.); by the NSF Polar program (grant no. OPP 1935870 and 1947040) (A.V.); and by NIH NIGMS (grant no. R35GM122543) (J.P.G.L.M.R.).

References

  • 1.Dong E, Du H, Gardner L. 2020. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis. 20, 533-534. ( 10.1016/S1473-3099(20)30120-1) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.World Health Organization. 2021. WHO coronavirus disease (COVID-19) dashboard. See https://covid19.who.int. [Google Scholar]
  • 3.Keele BF, et al. 2006. Chimpanzee reservoirs of pandemic and nonpandemic HIV-1. Science 313, 523-526. ( 10.1126/science.1126531) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Gage KL, Kosoy MY. 2005. Natural history of plague: perspectives from more than a century of research. Annu. Rev. Entomol. 50, 505-528. ( 10.1146/annurev.ento.50.071803.130337) [DOI] [PubMed] [Google Scholar]
  • 5.Taubenberger JK, Reid AH, Lourens RM, Wang R, Jin G, Fanning TG. 2005. Characterization of the 1918 influenza virus polymerase genes. Nature 437, 889. ( 10.1038/nature04230) [DOI] [PubMed] [Google Scholar]
  • 6.Zhou P, et al. 2020. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270-273. ( 10.1038/s41586-020-2012-7) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Letko M, Marzi A, Munster V. 2020. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat. Microbiol. 5, 562-569. ( 10.1038/s41564-020-0688-y) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Chou CF, et al. 2006. ACE2 orthologues in non-mammalian vertebrates (Danio, Gallus, Fugu, Tetraodon and Xenopus). Gene 377, 46-55. ( 10.1016/j.gene.2006.03.010) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Guth S, Visher E, Boots M, Brook CE. 2019. Host phylogenetic distance drives trends in virus virulence and transmissibility across the animal-human interface. Phil. Trans. R. Soc. B 374, 20190296. ( 10.1098/rstb.2019.0296) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.World Health Organization. 2020. SARS-CoV-2 mink-associated variant strain—Denmark. See www.who.int/home/cms-decommissioning. [Google Scholar]
  • 11.Oude Munnink BB, et al. 2020. Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans. Science 37, 172-177. ( 10.1126/science.abe5901) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Rodrigues JPGLM, Barrera-Vilarmau S, M C Teixeira J, Sorokina M, Seckel E, Kastritis PL, Levitt M. 2020. Insights on cross-species transmission of SARS-CoV-2 from structural modeling. PLoS Comput. Biol. 16, e1008449. ( 10.1371/journal.pcbi.1008449) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Davies NG et al. 2021. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science 372, eabg3055. ( 10.1126/science.abg3055) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Volz E, et al. 2021. Transmission of SARS-CoV-2 lineage B.1.1.7 in England: insights from linking epidemiological and genetic data. medRxiv, 2020.12.30.20249034.
  • 15.Rambaut A, et al. 2020. Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations. Virological. See https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563 (accessed on 28 January 2021).
  • 16.Tegally H, et al. 2020. Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa. medRxiv, 2020.12.21.20248640.
  • 17.Van Egeren D, et al. 2021. Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein. PLoS ONE 16, e0250780. ( 10.1371/journal.pone.0250780) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Bao L, et al. 2020. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature 583, 830-833. ( 10.1038/s41586-020-2312-y) [DOI] [PubMed] [Google Scholar]
  • 19.Montagutelli X, et al. 2021. The B1.351 and P.1 variants extend SARS-CoV-2 host range to mice. bioRxiv. 2021.03.18.436013. ( 10.1101/2021.03.18.436013) [DOI]
  • 20.Fischhoff IR, Castellanos AA, Rodrigues JPGLM, Varsani A, Han BA. 2021. Predicting the zoonotic capacity of mammals to transmit SARS-CoV-2. Figshare. [DOI] [PMC free article] [PubMed]
  • 21.Ahmed R, Hasan R, Siddiki AMAMZ, Islam MS. 2021. Host range projection of SARS-CoV-2: South Asia perspective. Infect. Genet. Evol. 87, 104670. ( 10.1016/j.meegid.2020.104670) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Damas J, et al. 2020. Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates. Proc. Natl Acad. Sci. USA 117, 22 311-22 322. ( 10.1073/pnas.2010146117) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Kumar A, Pandey SN, Pareek V, Narayan RK, Faiq MA, Kumari C. 2020. Predicting susceptibility for SARS-CoV-2 infection in domestic and wildlife animals using ACE2 protein sequence homology. Zoo Biol. 40, 79-85. ( 10.1002/zoo.21576) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Liu Z, et al. 2020. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. J. Med. Virol. 92, 595-601. ( 10.1002/jmv.25726) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Luan J, Jin X, Lu Y, Zhang L. 2020. SARS-CoV-2 spike protein favors ACE2 from Bovidae and Cricetidae. J. Med. Virol. 92, 1649-1656. ( 10.1002/jmv.25817) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Melin AD, Janiak MC, Marrone F III, Arora PS, Higham JP. 2020. Comparative ACE2 variation and primate COVID-19 risk. Commun. Biol. 3, 641. ( 10.1038/s42003-020-01370-w) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Huang X, Zhang C, Pearce R, Omenn GS, Zhang Y. 2020. Identifying the zoonotic origin of SARS-CoV-2 by modeling the binding affinity between the spike receptor-binding domain and host ACE2. J. Proteome Res. 19, 4844-4856. ( 10.1021/acs.jproteome.0c00717) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Lam SD, et al. 2020. SARS-CoV-2 spike protein predicted to form complexes with host receptor protein orthologues from a broad range of mammals. Sci. Rep. 10, 16471. ( 10.1038/s41598-020-71936-5) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Li Y, et al. 2020. SARS-CoV-2 and three related coronaviruses utilize multiple ACE2 orthologs and are potently blocked by an improved ACE2-Ig. J. Virol. 94, e01283-20. ( 10.1128/JVI.01283-20) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Liu Y, et al. 2021. Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2. Proc. Natl Acad. Sci. USA 118, e2025373118. ( 10.1073/pnas.2025373118) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Yan H, et al. 2021. ACE2 receptor usage reveals variation in susceptibility to SARS-CoV and SARS-CoV-2 infection among bat species. Nature Ecol. Evol. 5, 600-608. ( 10.1038/s41559-021-01407-1) [DOI] [PubMed] [Google Scholar]
  • 32.Zhao X, et al. 2020. Broad and differential animal angiotensin-converting enzyme 2 receptor usage by SARS-CoV-2. J. Virol. 94, e01283-20. ( 10.1128/JVI.01283-20) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.DeLiberto T, Shriner S. 2020. PRO/AH/EDR> COVID-19 update (536): animal, USA (UT) wild mink, 1st case. ProMED. See https://promedmail.org/promed-post/?id=8015608. [Google Scholar]
  • 34.ODA. 2020. Mink at affected Oregon farm negative for SARS-CoV-2, wildlife surveillance continues. 23 December. See https://odanews.wpengine.com/mink-at-affected-oregon-farm-negative-for-sars-cov-2-wildlife-surveillance-continues/.
  • 35.Shriner SA, et al. 2021. SARS-CoV-2 exposure in escaped mink, Utah, USA. Emerg. Infect. Dis. 27, 988-990. ( 10.3201/eid2703.204444) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Mathavarajah S, Stoddart AK, Gagnon GA, Dellaire G. 2021. Pandemic danger to the deep: the risk of marine mammals contracting SARS-CoV-2 from wastewater. Sci. Total Env. 760, 143346. ( 10.1016/j.scitotenv.2020.143346) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Deng W et al. 2020. Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in rhesus macaques. Nature Communications 11, 4400. ( 10.1038/s41467-020-18149-6) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Shi J, et al. 2020. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2. Science 368, 1016-1020. ( 10.1126/science.abb7015) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Rodrigues JPGLM, et al. 2013. Defining the limits of homology modeling in information-driven protein docking. Proteins 81, 2119-2128. ( 10.1002/prot.24382) [DOI] [PubMed] [Google Scholar]
  • 40.Sander C, Schneider R. 1991. Database of homology-derived protein structures and the structural meaning of sequence alignment. Proteins 9, 56-68. ( 10.1002/prot.340090107) [DOI] [PubMed] [Google Scholar]
  • 41.Fournier D, Luft FC, Bader M, Ganten D, Andrade-Navarro MA. 2012. Emergence and evolution of the renin-angiotensin-aldosterone system. J. Mol. Med. 90, 495-508. ( 10.1007/s00109-012-0894-z) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Han BA, Schmidt JP, Bowden SE, Drake JM. 2015. Rodent reservoirs of future zoonotic diseases. Proc. Natl Acad. Sci. USA 112, 7039-7044. ( 10.1073/pnas.1501598112) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Yang LH, Han BA. 2018. Data-driven predictions and novel hypotheses about zoonotic tick vectors from the genus Ixodes. BMC Ecol. 18, 7. ( 10.1186/s12898-018-0163-2) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Han BA, O'Regan SM, Paul Schmidt J, Drake JM. 2020. Integrating data mining and transmission theory in the ecology of infectious diseases. Ecol. Lett. 23, 1178-1188. ( 10.1111/ele.13520) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Han BA, Schmidt JP, Alexander LW, Bowden SE, Hayman DTS, Drake JM. 2016. Undiscovered bat hosts of Filoviruses. PLoS Negl. Trop. Dis. 10, e0004815. ( 10.1371/journal.pntd.0004815) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Han BA, et al. 2019. Confronting data sparsity to identify potential sources of Zika virus spillover infection among primates. Epidemics 27, 59-65. ( 10.1016/j.epidem.2019.01.005) [DOI] [PubMed] [Google Scholar]
  • 47.Yang X-L, et al. 2017. Genetically diverse Filoviruses in Rousettus and Eonycteris spp. bats, China, 2009 and 2015. Emerg. Infect. Dis. 23, 482-486. ( 10.3201/eid2303.161119) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Goldstein T, et al. 2018. The discovery of Bombali virus adds further support for bats as hosts of ebolaviruses. Nat. Microbiol. 3, 1084-1089. ( 10.1038/s41564-018-0227-2) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Sorokina M, Teixeira J, Barrera-Vilarmau S, Paschke R, Papasotiriou I, Rodrigues JPGLM, Kastritis PL. 2020. Structural models of human ACE2 variants with SARS-CoV-2 spike protein for structure-based drug design. Sci. Data 7, 309. ( 10.1038/s41597-020-00652-6) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Restif O, et al. 2012. Model-guided fieldwork: practical guidelines for multidisciplinary research on wildlife ecological and epidemiological dynamics. Ecol. Lett. 15, 1083-1094. ( 10.1111/j.1461-0248.2012.01836.x) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Lan J, et al. 2020. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581, 215-220. ( 10.1038/s41586-020-2180-5) [DOI] [PubMed] [Google Scholar]
  • 52.Fischhoff I, Castellanos AA, Rodrigues J, Varsani A, Han B. 2021. Models of ACE2 orthologs interacting with SARS-CoV-2 Spike RBD (canonical variant). ( 10.5281/zenodo.4517509) [DOI]
  • 53.Bonvin A, Rodrigues J. 2021. HADDOCK2.4 manual. See www.bonvinlab.org/software/haddock2.4/introduction (accessed on 19 October 2021). [Google Scholar]
  • 54.de Magalhães JP, Costa J. 2009. A database of vertebrate longevity records and their relation to other life-history traits. J. Evol. Biol. 22, 1770-1774. ( 10.1111/j.1420-9101.2009.01783.x) [DOI] [PubMed] [Google Scholar]
  • 55.Myhrvold NP, Baldridge E, Chan B, Sivam D, Freeman DL, Ernest SKM. 2015. An amniote life-history database to perform comparative analyses with birds, mammals, and reptiles: ecological archivesE096-269. Ecology 96, 3109. ( 10.1890/15-0846R.1) [DOI] [Google Scholar]
  • 56.Wilman H, Belmaker J, Simpson J, de la Rosa C, Rivadeneira MM, Jetz W. 2014. EltonTraits 1.0: species-level foraging attributes of the world's birds and mammals. Ecology 95, 2027. ( 10.1890/13-1917.1) [DOI] [Google Scholar]
  • 57.Jones KE, et al. 2009. PanTHERIA: a species-level database of life history, ecology, and geography of extant and recently extinct mammals: Ecological Archives E090-184. Ecology 90, 2648. ( 10.1890/08-1494.1) [DOI] [Google Scholar]
  • 58.Wilson DE, Reeder DM. 2005. Mammal species of the world: a taxonomic and geographic reference. Baltimore, MD: JHU Press. [Google Scholar]
  • 59.Greenwell B, Boehmke B, Cunningham J, GBM Developers. 2020. Generalized boosted regression models. See https://cran.r-project.org/web/packages/gbm/index.html. [Google Scholar]
  • 60.R Core Team. 2020. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. See www.R-project.org. [Google Scholar]
  • 61.Ulrich L, Wernike K, Hoffmann D, Mettenleiter TC, Beer M. 2020. Experimental infection of cattle with SARS-CoV-2. Emerg. Infect. Dis. 26, 2979-2981. ( 10.3201/eid2612.203799) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Ulrich L, Michelitsch A, Halwe N, Wernike K, Hoffmann D, Beer M. 2021. Experimental SARS-CoV-2 infection of bank voles. Emerg. Infect. Dis. 27, 1193-1195. ( 10.3201/eid2704.204945) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Bosco-Lauth AM, et al. 2020. Experimental infection of domestic dogs and cats with SARS-CoV-2: pathogenesis, transmission, and response to reexposure in cats. Proc. Natl Acad. Sci. USA 117, 26 382-26 388. ( 10.1073/pnas.2013102117) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Elith J, Leathwick JR, Hastie T. 2008. A working guide to boosted regression trees. J. Anim. Ecol. 77, 802-813. ( 10.1111/j.1365-2656.2008.01390.x) [DOI] [PubMed] [Google Scholar]
  • 65.Fagre A, et al. 2021. SARS-CoV-2 infection, neuropathogenesis and transmission among deer mice: Implications for spillback to New World rodents. PLoS Pathog. 17, e1009585. ( 10.1371/journal.ppat.1009585) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Griffin BD, et al. 2021. SARS-CoV-2 infection and transmission in the North American deer mouse. Nat. Commun. 12, 3612. ( 10.1038/s41467-021-23848-9) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Freuling CM, et al. 2020. Susceptibility of raccoon dogs for experimental SARS-CoV-2 infection. Emerg. Infect. Dis. 26, 2982-2985. ( 10.3201/eid2612.203733) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Hall JS, et al. In press. Experimental challenge of a North American bat species, big brown bat (Eptesicus fuscus), with SARS-CoV-2. Transbound. Emerg. Dis. ( 10.1111/tbed.13949) [DOI] [PubMed] [Google Scholar]
  • 69.Schlottau K, et al. 2020. SARS-CoV-2 in fruit bats, ferrets, pigs, and chickens: an experimental transmission study. Lancet Microbe 1, e218-e225. ( 10.1016/S2666-5247(20)30089-6) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Lam TTY, et al. 2020. Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins. Nature 583, 282-285. ( 10.1038/s41586-020-2169-0) [DOI] [PubMed] [Google Scholar]
  • 71.Lehmann D, Halbwax ML, Makaga L, Whytock R, Ndindiwe Malata L, Bombenda Mouele W, Momboua BR, Koumba Pambo AF, White LJT. 2020. Pangolins and bats living together in underground burrows in Lopé National Park, Gabon. Afr. J. Ecol. 58, 540-542. ( 10.1111/aje.12759) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Palmer MV et al. 2021. Susceptibility of white-tailed deer (Odocoileus virginianus) to SARS-CoV-2. J. Virol. 95, e00083-21. ( 10.1128/JVI.00083-21) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Tsuda S, et al. 2012. Genomic and serological detection of bat coronavirus from bats in the Philippines. Arch. Virol. 157, 2349-2355. ( 10.1007/s00705-012-1410-z) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Zhou H, et al. 2020. A novel bat coronavirus closely related to SARS-CoV-2 contains natural insertions at the S1/S2 cleavage site of the spike protein. Curr. Biol. 30, 2196-2203.e3. ( 10.1016/j.cub.2020.05.023) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Hul V, et al. 2021. A novel SARS-CoV-2 related coronavirus in bats from Cambodia. bioRxiv., 2021.01.26.428212. ( 10.1101/2021.01.26.428212) [DOI]
  • 76.Mou H et al. 2021. Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2. PLoS Pathogens 17, e1009501. ( 10.1371/journal.ppat.1009501) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Wacharapluesadee S, et al. 2021. Evidence for SARS-CoV-2 related coronaviruses circulating in bats and pangolins in Southeast Asia. Nat. Commun. 12, 972. ( 10.1038/s41467-021-21240-1) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Pulliam JRC, et al. 2012. Agricultural intensification, priming for persistence and the emergence of Nipah virus: a lethal bat-borne zoonosis. J. R. Soc. Interface 9, 89-101. ( 10.1098/rsif.2011.0223) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Plowright RK, et al. 2015. Ecological dynamics of emerging bat virus spillover. Proc. R. Soc. B 282, 20142124. ( 10.1098/rspb.2014.2124) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Kessler MK, et al. 2018. Changing resource landscapes and spillover of henipaviruses. Ann. N. Y. Acad. Sci. 1429, 78-99. ( 10.1111/nyas.13910) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Peel AJ, Field HE, Aravena MR, Edson D, McCallum H, Plowright RK, Prada D. 2020. Coronaviruses and Australian bats: a review in the midst of a pandemic. Aust. J. Zool. 67, 346-360. ( 10.1071/ZO20046) [DOI] [Google Scholar]
  • 82.Bordes F, Blasdell K, Morand S. 2015. Transmission ecology of rodent-borne diseases: new frontiers. Integr. Zool. 10, 424-435. ( 10.1111/1749-4877.12149) [DOI] [PubMed] [Google Scholar]
  • 83.Ostfeld RS, Canham CD, Oggenfuss K, Winchcombe RJ, Keesing F. 2006. Climate, deer, rodents, and acorns as determinants of variation in lyme-disease risk. PLoS Biol. 4, e145. ( 10.1371/journal.pbio.0040145) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Machtinger ET, Williams SC. 2020. Practical guide to trapping Peromyscus leucopus (Rodentia: Cricetidae) and Peromyscus maniculatus for vector and vector-borne pathogen surveillance and ecology. J. Insect Sci. 20, 5. ( 10.1093/jisesa/ieaa028) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Morand S, et al. 2015. Global parasite and Rattus rodent invasions: the consequences for rodent-borne diseases. Integr. Zool. 10, 409-423. ( 10.1111/1749-4877.12143) [DOI] [PubMed] [Google Scholar]
  • 86.Hamdan NES, Ng YL, Lee WB, Tan CS, Khan FAA, Chong YL. 2017. Rodent species distribution and Hantavirus Seroprevalence in residential and forested areas of Sarawak, Malaysia. Trop. Life Sci. Res. 28, 151-159. ( 10.21315/tlsr2017.28.1.11) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Louys J, Herrera MB, Thomson VA, Wiewel AS, Donnellan SC, O'Connor S, Aplin K. 2020. Expanding population edge craniometrics and genetics provide insights into dispersal of commensal rats through Nusa Tenggara, Indonesia. Rec. Aust. Mus. 72, 287-302. ( 10.3853/j.2201-4349.72.2020.1730) [DOI] [Google Scholar]
  • 88.Becker DJ, Washburne AD, Faust CL, Pulliam JRC, Mordecai EA, Lloyd-Smith JO, Plowright RK. 2019. Dynamic and integrative approaches to understanding pathogen spillover. Phil. Trans. R. Soc. B 374, 20190014. ( 10.1098/rstb.2019.0014) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Plowright RK, Parrish CR, McCallum H, Hudson PJ, Ko AI, Graham AL, Lloyd-Smith JO. 2017. Pathways to zoonotic spillover. Nat. Rev. Microbiol. 15, 502-510. ( 10.1038/nrmicro.2017.45) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Morris DH, et al. 2020. The effect of temperature and humidity on the stability of SARS-CoV-2 and other enveloped viruses. bioRxiv. ( 10.1101/2020.10.16.341883) [DOI]
  • 91.Bean AGD, Baker ML, Stewart CR, Cowled C, Deffrasnes C, Wang LF, Lowenthal JW. 2013. Studying immunity to zoonotic diseases in the natural host—keeping it real. Nat. Rev. Immunol. 13, 851-861. ( 10.1038/nri3551) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Letko M, Seifert SN, Olival KJ, Plowright RK, Munster VJ. 2020. Bat-borne virus diversity, spillover and emergence. Nat. Rev. Microbiol. 18, 461-471. ( 10.1038/s41579-020-0394-z) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.OIE. 2021. Events in animals. See https://www.oie.int/en/scientific-expertise/specific-information-and-recommendations/questions-and-answers-on-2019novel-coronavirus/events-in-animals/ (accessed on 28 January 2021).
  • 94.Sawatzki K, Hill NJ, Puryear WB, Foss AD, Stone JJ, Runstadler JA. 2021. Host barriers to SARS-CoV-2 demonstrated by ferrets in a high-exposure domestic setting. Proc. Natl Acad. Sci. USA 118, e2025601118. ( 10.1073/pnas.2025601118) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Mykytyn AZ, et al. 2021. Susceptibility of rabbits to SARS-CoV-2. Emerg. Microbes Infect. 10, 1-7. ( 10.1080/22221751.2020.1868951) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Ruiz-Arrondo I, Portillo A, Palomar AM, Santibanez S, Santibanez P, Cervera C, Oteo JA. 2020. Detection of SARS-CoV-2 in pets living with COVID-19 owners diagnosed during the COVID-19 lockdown in Spain: a case of an asymptomatic cat with SARS-CoV-2 in Europe. bioRxiv. ( 10.1101/2020.05.14.20101444) [DOI]
  • 97.Peel AJ, et al. 2019. Synchronous shedding of multiple bat paramyxoviruses coincides with peak periods of Hendra virus spillover. Emerg. Microbes Infect. 8, 1314-1323. ( 10.1080/22221751.2019.1661217) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Cook JA, et al. 2020. Integrating biodiversity infrastructure into pathogen discovery and mitigation of emerging infectious diseases. Bioscience 70, 531-534. ( 10.1093/biosci/biaa064) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Thompson CW, et al. 2021. Preserve a voucher specimen! The critical need for integrating natural history collections in infectious disease studies. MBio 12, e02698-20. ( 10.1128/mBio.02698-20) [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Citations

  1. Fischhoff IR, Castellanos AA, Rodrigues JPGLM, Varsani A, Han BA. 2021. Predicting the zoonotic capacity of mammals to transmit SARS-CoV-2. Figshare. [DOI] [PMC free article] [PubMed]
  2. Fischhoff I, Castellanos AA, Rodrigues J, Varsani A, Han B. 2021. Models of ACE2 orthologs interacting with SARS-CoV-2 Spike RBD (canonical variant). ( 10.5281/zenodo.4517509) [DOI]

Supplementary Materials

Data Availability Statement

All data, code and models required for recreating our structural modelling analysis with HADDOCK are available from Zenodo: https://doi.org/10.5281/zenodo.4517509) [52]. All data and code required for BRT modelling using species trait data are available from GitHub: https://github.com/HanLabDiseaseEcology/zoonotic_capacity. Additional methods, tables, figures and files of our model predictions can be found in the supplemental material of this article and on Figshare: https://doi.org/10.25390/caryinstitute.c.5293339.v5 [20].


Articles from Proceedings of the Royal Society B: Biological Sciences are provided here courtesy of The Royal Society

RESOURCES